C-MER Medical Holdings Limited (stock code 03309) published a Next Day Disclosure Return dated 02 December 2025. According to the report, 160,000 shares were repurchased on 02 December 2025 for HKD 1.75 to HKD 1.76 per share, totaling HKD 280,080. These repurchased shares represent approximately 0.0129% of the company’s previously issued share capital (excluding treasury shares).

Following this transaction, the number of treasury shares increased to 18,080,000. The number of issued shares excluding treasury shares stood at 1,237,480,870, and the total number of issued shares remained 1,255,560,870 as of 02 December 2025. The report also highlighted a series of share repurchases from July 2024 to May 2025 for cancellation, which have not yet been fully processed. The repurchase mandate dated 19 May 2025 currently authorizes up to 125,556,087 shares to be repurchased. No information was provided regarding any new share issuance or sales of treasury shares during the 30-day period following this repurchase.